Inhibition of monoamine oxidase by 8-[(phenylethyl)sulfanyl]caffeine analogues

被引:24
|
作者
Mostert, Samantha
Mentz, Wayne
Petzer, Anel [1 ]
Bergh, Jacobus J.
Petzer, Jacobus P. [1 ]
机构
[1] North West Univ, Sch Pharm, Unit Drug Res & Dev, ZA-2520 Potchefstroom, South Africa
基金
英国医学研究理事会; 新加坡国家研究基金会;
关键词
Monoamine oxidase; Sulfanylcaffeine; Sulfinylcaffeine; Reversible inhibition; Selective inhibition; Caffeine; Structure-activity relationship; HUMAN-BRAIN; MAO-B; METABOLISM; DOPAMINE; 3,4-DIHYDROXYPHENYLACETALDEHYDE;
D O I
10.1016/j.bmc.2012.10.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In a previous study we have investigated the monoamine oxidase (MAO) inhibitory properties of a series of 8-sulfanylcaffeine analogues. Among the compounds studied, 8-[(phenylethyl) sulfanyl] caffeine (IC50 = 0.223 mu M) was found to be a particularly potent inhibitor of the type B MAO isoform. In an attempt to discover potent MAO inhibitors and to further examine the structure-activity relationships (SAR) of MAO inhibition by 8-sulfanylcaffeine analogues, in the present study a series of 8-[(phenylethyl)sulfanyl] caffeine analogues were synthesized and evaluated as inhibitors of human MAO-A and -B. The results document that substitution on C3 and C4 of the phenyl ring with alkyl groups and halogens yields 8-[( phenylethyl) sulfanyl] caffeine analogues which are potent and selective MAO-B inhibitors with IC50 values ranging from 0.017 to 0.125 mu M. The MAO inhibitory properties of a series of 8-sulfinylcaffeine analogues were also examined. The results show that, compared to the corresponding 8-sulfanylcaffeine analogues, the 8-sulfinylcaffeins are weaker MAO-B inhibitors. Both the 8-sulfanylcaffeine and 8-sulfinylcaffeine analogues were found to be weak MAO-A inhibitors. This study also reports the MAO inhibition properties of selected 8-[(phenylpropyl) sulfanyl] caffeine analogues. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:7040 / 7050
页数:11
相关论文
共 50 条
  • [21] Combined inhibition of monoamine oxidase
    Nikol'skaya, EB
    Yagodina, OV
    Khovanskikh, AE
    DOKLADY AKADEMII NAUK, 1999, 365 (06) : 829 - 831
  • [22] Inhibition of monoamine oxidase by metronidazole
    O. Befani
    E. Grippa
    L. Saso
    P. Turini
    B. Mondovi
    Inflammation Research, 2001, 50 (Suppl 2) : 136 - 137
  • [23] INHIBITION OF MONOAMINE OXIDASE ISOZYMES
    RONA, E
    WOLLEMANN, M
    ACTA PHYSIOLOGICA ACADEMIAE SCIENTIARUM HUNGARICAE, 1971, 39 (1-3): : 154 - +
  • [24] MONOAMINE-OXIDASE INHIBITION
    TIPTON, KF
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1994, 22 (03) : 764 - 768
  • [25] INHIBITION OF BRAIN MONOAMINE OXIDASE
    DAVISON, AN
    BULLETIN DE LA SOCIETE DE CHIMIE BIOLOGIQUE, 1958, 40 (12): : 1737 - 1742
  • [26] Inhibition of monoamine oxidase by higenamine
    Lee, SS
    Yun-Choi, HS
    Kim, EI
    Lee, MK
    MEDICAL SCIENCE RESEARCH, 1999, 27 (01): : 71 - 72
  • [27] INHIBITION OF MONOAMINE OXIDASE BY STYRYLQUINOLINIUMS
    TAYLOR, RJ
    MARKLEY, E
    ELLENBOGEN, L
    BIOCHEMICAL PHARMACOLOGY, 1967, 16 (01) : 79 - +
  • [28] Inhibition of monoamine oxidase by pirlindole analogues: 3D-QSAR and CoMFA analysis
    Medvedev, AE
    Veselovsky, AV
    Shvedov, VI
    Tikhonova, OV
    Moskvitina, TA
    Fedotova, OA
    Axenova, LN
    Kamyshanskaya, NS
    Kirkel, AZ
    Ivanov, AS
    JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 1998, 38 (06): : 1137 - 1144
  • [29] ON IRREVERSIBILITY OF MONOAMINE OXIDASE INHIBITION
    PLANZ, G
    QUIRING, K
    PALM, D
    NAUNYN-SCHMIEDEBERGS ARCHIV FUR PHARMAKOLOGIE, 1970, 266 (4-5): : 424 - &
  • [30] ANION INHIBITION OF MONOAMINE OXIDASE
    VANWOERT, MH
    COTZIAS, GC
    BIOCHEMICAL PHARMACOLOGY, 1966, 15 (03) : 275 - &